New APA journal research on cannabis use disorder and stigma provides critical clinical insights as cannabis legalization expands and patient presentations become more complex. Understanding both the disorder profile and stigma barriers helps clinicians better identify, assess, and treat problematic cannabis use patterns.
The American Psychological Association journals are featuring research examining cannabis use disorder characteristics and associated stigma factors. This research comes at a critical time when cannabis use disorder diagnoses are increasing alongside widespread legalization, creating new challenges for clinicians in differentiating therapeutic use from problematic patterns. The stigma component is particularly relevant as patients may underreport cannabis-related problems due to social or legal concerns, even in medical contexts.
“This research timing is crucial—we’re seeing more patients with complex cannabis use patterns, and many avoid honest discussions about problematic use due to stigma. Having evidence-based frameworks for both identifying disorder patterns and addressing stigma barriers will directly improve our clinical conversations.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What is Cannabis Use Disorder?
Cannabis Use Disorder is a medical condition characterized by problematic cannabis use leading to clinically significant impairment or distress. It involves continued use despite negative consequences and can include symptoms like tolerance, withdrawal, and inability to control use.
How does cannabis use affect mental health?
Cannabis use can have complex effects on mental health, potentially worsening existing conditions like anxiety and depression in some individuals. Regular use may also increase the risk of developing certain psychiatric disorders, particularly in vulnerable populations.
What should clinicians look for when assessing cannabis use in patients?
Clinicians should assess frequency and amount of use, impact on daily functioning, and any withdrawal symptoms. They should also evaluate for co-occurring mental health conditions and consider how cannabis use may be affecting the patient’s overall treatment plan.
What clinical screening tools are available for cannabis use disorders?
Various validated screening tools exist, including the Cannabis Use Disorder Identification Test (CUDIT) and DSM-5 criteria-based assessments. These tools help clinicians systematically evaluate the severity of cannabis use and its impact on patients’ lives.
Why is this topic considered clinically relevant now?
With increasing cannabis legalization and changing social attitudes, healthcare providers are seeing more patients with cannabis-related concerns. Early identification and appropriate clinical response to cannabis use disorders has become increasingly important for patient care.